INSIGHTEC

MR-guided Focused Ultrasound Systems

Company Name
Updating Date
Neurotech Category
Market Category
Target Market
Technologies
Company Founded Year
Company Number of Employees
INSIGHTEC
02/07/2022
NeuroSurgery | NeuroDevices
Medical devices | Medical equipment
Medical use (pharma, nerve damage rehabilitation, neurodiagnostics. inc. early diagnosis)
Neuromodulation Interventions | Non-Invasive (TMS | tDCS | tACS)
01/01/1999
"201-500"

INSIGHTEC develops and distributes the Exablate platform, which provides noninvasive treatments for a variety of oncology and gynecology indications. The Exablate platform uses MRgFUS technology, which combines high-intensity focused ultrasound guided by magnetic resonance imaging. Focused ultrasound waves are used to safely ablate targeted tissue, ensuring a high rate of effectiveness with minimal side effects.



INSIGHTEC obtained FDA approval for its technology in 2016 and 2018. It is continuously investing in and expanding its current and investigational applications, ranging from functional neurosurgery to oncology and gynecology.